Fortress Biotech is a biopharmaceutical company. Through its partner company, Co. markets the following dermatology products: Ximino®, which treats only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox®, which is used as adjunctive therapy for severe acne; Exelderm®, which treats tinea infection; Ceracade®, which is used to treat dry skin conditions and to manage and relieve the burning and itching associated with various types of dermatitis and radiation dermatitis; ad Luxamend®, which is used for the dressing and management of superficial wounds, minor abrasions, dermal ulcers, donor sites, first- and second-degree burns, and radiation dermatitis.

Preferred: FBIOP